Immunogenicity of an AI-designed personalized neoantigen vaccine, EVX-01, in combination with anti-PD-1 therapy in patients with metastatic melanoma. This is an ASCO Meeting Abstract from the 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback